Sarita Rajender Potlapally

Selective ATP competitive leads of CDK4: Discovery by 3D-QSAR pharmacophore mapping and molecular docking approach

Rohini Rondla, Lavanya Souda Padmarao, Vishwanath Ramatenki et al. · Computational Biology and Chemistry · 2017 · 29 citations

Molecular Recognition, Drug Target, Biochemistry +10

Homology modeling and virtual screening of ubiquitin conjugation enzyme E2A for designing a novel selective antagonist against cancer

Vishwanath Ramatenki, Sarita Rajender Potlapally, Rama Krishna Dumpati et al. · Journal of Receptors and Signal Transduction · 2014 · 28 citations · Full text

Drug Target, Engineering, Novel Selective Antagonist +21

Structure-based identification of potential novel inhibitors targeting FAM3B (PANDER) causing type 2 diabetes mellitus through virtual screening

Goverdhan Lanka, Revanth Bathula, Mahendar Dasari et al. · Journal of Receptors and Signal Transduction · 2019 · 25 citations

Drug Target, Engineering, Insulin Signaling +24

Homology Modeling, Virtual Screening, Prime-MMGBSA, AutoDock-Identification of Inhibitors of FGR Protein

Narasimha Muddagoni, Revanth Bathula, Mahender Dasari et al. · Biointerface Research in Applied Chemistry · 2020 · 23 citations · Full text

Molecular Biology, Homology Modeling, Tumor Biology +20

Identification of novel leads applying<i>in silico</i>studies for Mycobacterium multidrug resistant (MMR) protein

Vasavi Malkhed, Kiran Kumar Mustyala, Sarita Rajender Potlapally et al. · Journal of Biomolecular Structure and Dynamics · 2013 · 21 citations